• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Sable Bio: Venture Capital Funding History

Sable Bio

To add a bio or update company history click update information.

News from Sable Bio

    Sable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firmsSable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firms
    Sable Bio
    11 Feb 2026

    Sable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firms

    Sable Bio builds AI tools to assess drug target safety in pharmaceutical research. Its platform analyses scientific data to identify potential toxicity risks earlier in development.

Sable Bio
  • Life Sciences
  • London, United Kingdom
  • £2.7m
  • sablebio.com
  • Update Information

More venture news

  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn